009300 — Sam-A Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual income statement for Sam-A Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	54,666	81,700	97,211	95,581	77,799
Cost of Revenue
Gross Profit	32,658	50,163	61,624	60,828	46,358
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	48,618	63,446	73,711	71,114	66,820
Operating Profit	6,048	18,253	23,500	24,466	10,979
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,335	18,400	28,476	29,270	16,033
Provision for Income Taxes
Net Income After Taxes	3,392	11,912	21,374	22,080	12,940
Net Income Before Extraordinary Items
Net Income	3,392	11,912	21,374	22,080	12,940
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,392	11,912	21,374	22,080	12,940
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	521	1,953	3,481	3,618	2,116
Dividends per Share